Glenmark Pharma To Study Potential COVID-19 Drug Combo; Shares Gain 5th Straight Day

Shares of Glenmark Pharma rose as much as 2.4 percent to Rs 360.5 apiece for the fifth straight day on Tuesday after the drugmaker informed the exchanges that it will be commencing a new phase of 3 clinical trials on hospitalised

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/2THic4c